BackNektar Therapeutics Overview

Nektar Therapeutics Net Income

Profitability analysis for NKTR.

Quarterly Net Income

-$44.90M
11.75% YoY

As of Mar 2026

Annual Net Income (TTM)

-$158.10M
18.83% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...